• Dr. Victoria Atkinson appointed as Managing Director and CEO effective from 18 May 2026
• Extensive experience in clinical, operational, and governance leadership roles across Australia's healthcare sector
• Current Chief Medical Officer at Healthscope overseeing clinical strategy, governance, risk, and medical affairs

Monash IVF Group Ltd (ASX: MVF), a leading provider of assisted reproductive services and specialist women's imaging and diagnostic services in Australia, Singapore, Indonesia, and Malaysia, has announced the appointment of Dr. Victoria Atkinson as the new Managing Director and Chief Executive Officer (CEO), effective from 18 May 2026. Dr. Atkinson is a distinguished healthcare executive with over 30 years of experience spanning clinical, operational, and governance leadership across Australia's public, private, and not-for-profit health sectors. Her current role is the Chief Medical Officer at Healthscope, where she oversees clinical strategy, governance, risk, medical affairs, and medico-legal portfolios across a network of 36 hospitals, 15 intensive care units, and 11 mental health facilities nationwide. Prior to Healthscope, Dr. Atkinson held senior positions at St Vincent's Health Australia and Melbourne Health, combining her clinical expertise with leadership roles. The Monash IVF Group Chairman, Richard Davis, welcomed Dr. Atkinson to the Board, stating that the Board is impressed with her unique combination of clinical and financial experience, which will be valuable in leading the company's people, doctors, and patients. The announcement also includes the departure of the interim Chief Financial Officer, Mr. Andrew MacLachlan, on 21 November 2025, with a search underway for a replacement, while Mr. Malik Jainudeen continues as the Acting Chief Executive Officer until Dr. Atkinson's commencement in 2026.